| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972347 | The Journal of Heart and Lung Transplantation | 2008 | 4 Pages |
Abstract
After transplantation, sCD30 levels are consistently suppressed, but BOS is not prevented, indicating that sCD30 cannot be used as a biomarker to predict BOS after transplantation in the regimen employed.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Johanna M. MD, Henny G. PhD, Annelieke W.M. Paantjens, Diana A. MD, Walter G.J. van Ginkel, Jules M.M. MD, PhD, Ed A. MD, PhD,